{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"glycogen-storage-disorder-due-to-hepatic-glycogen-synthase-deficiency","columns":[{"gene":"","key":"population-440599282329a735ccd0","label":"Glycogen storage disease 0, liver","mondoId":"MONDO:0009414","onsetQualifier":null,"originColumnKey":"MONDO:0009414/OMIM:240600","originalViews":[{"key":"MONDO:0009414/OMIM:240600","label":"Glycogen storage disease 0, liver","scopeLabel":"OMIM:240600","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["3284d6bcf8c63ccb1320a0f017c0f068e59b30f8f23e8e7670b53620add7af41","66eb2bdae3ce9acc838b66ffd4b736726ae43965bf3e0f9ef9b5b08d04b7e47b","68bb57d55b9757dd1d654930773cd3346ca4ee03d12ded0a32be92bc0f569538","6c032d0c9c441dde07843c9bb68e47066d0cd300e9186b8ec0be4eeba87ebe1c","952a72076a584a23b7cff10ac810e6c99ff913738ed2fc3dcab4fbdb1d156caf","f00a86806526af7595201c792de0b8964b60a7c6fb4f6067a187e0c6d3d8e805"],"recordQualifiers":{},"scopeLabel":"OMIM:240600","sourceIds":["OMIM:240600"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."},{"gene":"","key":"population-76e707a91ec9d199f914","label":"Glycogen storage disease due to hepatic glycogen synthase deficiency","mondoId":"MONDO:0009414","onsetQualifier":null,"originColumnKey":"MONDO:0009414/ORPHA:2089","originalViews":[{"key":"MONDO:0009414/ORPHA:2089","label":"Glycogen storage disease due to hepatic glycogen synthase deficiency","scopeLabel":"ORPHA:2089","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["09f2eec39f6a8d6ead7756199519a3185516205d55e0acd03004a1b5dee58383","1220b1486caa6a4bca23b508768bfaa05efd02dfc02fa38d1605556a2bbabae2","16c33ad00a50cf489ec2a5ad42de1bf80b07b827e703aa56af3e6f3d38cdc5a9","1ea68a44432f70fd2c6a72755b7ec5237a0985038bad8a401bd426c504994ba2","359df3821f82b6d5edf3db58e59ad079f5e7c0221c38cb36f908bbb826383660","36d21d2be2b90fbb26b0ff58788219f359580e0cf3ace133c4d3428c4045665e","4fa4b997d963a5e763ca9634e447dbbf4df068ac96e35a59163b6defc1421c02","5c32dc3124cfecaf4c8907819a868b3c4c512221e1a3d75591646167a3571164","8d8ed540e725285490262a456e807bcd7baf12286a609d4b86015973f6ee7c22","8e1ba19ac89a5a2bc1d9e0172ba080b09bd68b49c2e52c584be4336d07a8b5c0","9fafe0256c12ed93e8a396d4f37cc40c6de5d1b86c1969a29463e7c25903520b","bfd14e327003bb87f0caef6b153cdd3c5c9965f156e98404207ec3d49d37fbbe","d66a748a831364ac6067d36bbd0723058ee01de7d7627aab896c6b3288df84bb","fc1d0fa8eee100a2f26fd4f727ed02f03c3cdeef4d48440ef322a50d41d8f177"],"recordQualifiers":{},"scopeLabel":"ORPHA:2089","sourceIds":["ORPHA:2089"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-440599282329a735ccd0","population-76e707a91ec9d199f914"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0011024","HP:0002910","HP:0001508","HP:0003162","HP:0001263","HP:0003076","HP:0003077"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":20,"sourceGroups":{"omim":6,"orphanet":14}},"features":[{"hpoId":"HP:0011024","label":"Abnormality of the gastrointestinal tract","primary":true},{"hpoId":"HP:0002910","label":"Elevated circulating hepatic transaminase concentration","primary":true},{"hpoId":"HP:0001508","label":"Failure to thrive","primary":true},{"hpoId":"HP:0003162","label":"Fasting hypoglycemia","primary":true},{"hpoId":"HP:0001263","label":"Global developmental delay","primary":true},{"hpoId":"HP:0003076","label":"Glycosuria","primary":true},{"hpoId":"HP:0003077","label":"Hyperlipidemia","primary":true},{"hpoId":"HP:0002151","label":"Increased circulating lactate concentration","primary":false},{"hpoId":"HP:0000737","label":"Irritability","primary":false},{"hpoId":"HP:0002919","label":"Ketonuria","primary":false},{"hpoId":"HP:0001946","label":"Ketosis","primary":false},{"hpoId":"HP:0012734","label":"Ketotic hypoglycemia","primary":false},{"hpoId":"HP:0001254","label":"Lethargy","primary":false},{"hpoId":"HP:0001998","label":"Neonatal hypoglycemia","primary":false},{"hpoId":"HP:0011998","label":"Postprandial hyperglycemia","primary":false},{"hpoId":"HP:0001250","label":"Seizure","primary":false},{"hpoId":"HP:0004322","label":"Short stature","primary":false}],"ledeHtml":"Glycogen storage disease type 0 (also known as GSD 0) is a condition caused by the body&#x27;s inability to form a complex sugar called glycogen, which is a major source of stored energy in the body. GSD 0 has two types: in muscle GSD 0, glycogen formation in the muscles is impaired, and in liver GSD 0, glycogen formation in the liver is impaired. The signs and symptoms of muscle GSD 0 typically begin in early childhood. Affected individuals often experience muscle pain and weakness or episodes of fainting (syncope) following moderate physical activity, such as walking up stairs. The loss of consciousness that occurs with fainting typically lasts up to several hours. Some individuals with muscle GSD 0 have a disruption of the heart&#x27;s normal rhythm (arrhythmia) known as long QT syndrome. In all affected individuals, muscle GSD 0 impairs the heart&#x27;s ability to effectively pump blood and increases the risk of cardiac arrest and sudden death, particularly after physical activity. Sudden death from cardiac arrest can occur in childhood or adolescence in people with muscle GSD 0. Individuals with liver GSD 0 usually show signs and symptoms of the disorder in infancy. People with this disorder develop low blood sugar (glucose), known as hypoglycemia, after going long periods of time without food (fasting). Signs of hypoglycemia become apparent when affected infants begin sleeping through the night and stop late-night feedings; these infants exhibit extreme tiredness (lethargy), pale skin (pallor), and nausea. During episodes of fasting, ketone levels in the blood may increase (ketosis). Ketones are molecules produced during the breakdown of fats, which occurs when stored sugars (such as glycogen) are unavailable. These short-term signs and symptoms of liver GSD 0 often improve when food is eaten and glucose levels in the body return to normal. The features of liver GSD 0 vary; they can be mild and go unnoticed for years, or they can include developmental delay and growth failure.","mondoId":"MONDO:0009414","node":{"canonicalSlug":"glycogen-storage-disorder-due-to-hepatic-glycogen-synthase-deficiency","comparisons":[{"documentSha256":"50185f461894f9695d23d2c6b2fbff0e49f378cebc2a2321ed504e17e92e636b","key":"legacy-glycogen-storage-disorder-due-to-hepatic-glycogen-synthase-deficiency","kind":"legacy","label":"glycogen storage disorder due to hepatic glycogen synthase deficiency","memberIds":["MONDO:0009414"],"mondoId":"MONDO:0009414","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/glycogen-storage-disorder-due-to-hepatic-glycogen-synthase-deficiency.50185f461894f9695d23d2c6b2fbff0e49f378cebc2a2321ed504e17e92e636b.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"summary","independentCorroborationEstablished":false,"matchMethod":"automatic-identity-and-attribution","name":"Glycogen storage disorder due to hepatic glycogen synthase deficiency","originalSourceId":"ORPHA:2089","paragraphs":["Glycogen storage disease type 0 (also known as GSD 0) is a condition caused by the body's inability to form a complex sugar called glycogen, which is a major source of stored energy in the body. GSD 0 has two types: in muscle GSD 0, glycogen formation in the muscles is impaired, and in liver GSD 0, glycogen formation in the liver is impaired. The signs and symptoms of muscle GSD 0 typically begin in early childhood. Affected individuals often experience muscle pain and weakness or episodes of fainting (syncope) following moderate physical activity, such as walking up stairs. The loss of consciousness that occurs with fainting typically lasts up to several hours. Some individuals with muscle GSD 0 have a disruption of the heart's normal rhythm (arrhythmia) known as long QT syndrome. In all affected individuals, muscle GSD 0 impairs the heart's ability to effectively pump blood and increases the risk of cardiac arrest and sudden death, particularly after physical activity. Sudden death from cardiac arrest can occur in childhood or adolescence in people with muscle GSD 0. Individuals with liver GSD 0 usually show signs and symptoms of the disorder in infancy. People with this disorder develop low blood sugar (glucose), known as hypoglycemia, after going long periods of time without food (fasting). Signs of hypoglycemia become apparent when affected infants begin sleeping through the night and stop late-night feedings; these infants exhibit extreme tiredness (lethargy), pale skin (pallor), and nausea. During episodes of fasting, ketone levels in the blood may increase (ketosis). Ketones are molecules produced during the breakdown of fats, which occurs when stored sugars (such as glycogen) are unavailable. These short-term signs and symptoms of liver GSD 0 often improve when food is eaten and glucose levels in the body return to normal. The features of liver GSD 0 vary; they can be mild and go unnoticed for years, or they can include developmental delay and growth failure."],"rawAttribution":"MONDO:0009414","reviewed":null,"scope":"exact","source":"GARD","sourceRelease":"2026-10-21T17:04:04Z","upstream":"GARD:0002513","url":"https://rarediseases.info.nih.gov/diseases/2513"},"ownColumnKeys":["population-440599282329a735ccd0","population-76e707a91ec9d199f914"],"publication":"published","relationships":[{"kind":"parent","label":"disorder of glycogen metabolism","mondoId":"MONDO:0002412","slug":"disorder-of-glycogen-metabolism"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[{"reason":"multiple-identity-targets","source":"MedlinePlus","url":"https://medlineplus.gov/genetics/condition/glycogen-storage-disease-type-0"}],"translation":"pending"},"records":[{"frequencyKind":"range","key":"09f2eec39f6a8d6ead7756199519a3185516205d55e0acd03004a1b5dee58383","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:2089","disease_name":"Glycogen storage disease due to hepatic glycogen synthase deficiency","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001946","is_excluded":false,"label":"Ketosis","onset_id":null,"reference":"ORPHA:2089","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"1220b1486caa6a4bca23b508768bfaa05efd02dfc02fa38d1605556a2bbabae2","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:2089","disease_name":"Glycogen storage disease due to hepatic glycogen synthase deficiency","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000737","is_excluded":false,"label":"Irritability","onset_id":null,"reference":"ORPHA:2089","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"16c33ad00a50cf489ec2a5ad42de1bf80b07b827e703aa56af3e6f3d38cdc5a9","raw":{"aspect":"P","body_system":"digestive","disease_id":"ORPHA:2089","disease_name":"Glycogen storage disease due to hepatic glycogen synthase deficiency","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0011024","is_excluded":false,"label":"Abnormality of the gastrointestinal tract","onset_id":null,"reference":"ORPHA:2089","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"1ea68a44432f70fd2c6a72755b7ec5237a0985038bad8a401bd426c504994ba2","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:2089","disease_name":"Glycogen storage disease due to hepatic glycogen synthase deficiency","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002910","is_excluded":false,"label":"Elevated circulating hepatic transaminase concentration","onset_id":null,"reference":"ORPHA:2089","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"3284d6bcf8c63ccb1320a0f017c0f068e59b30f8f23e8e7670b53620add7af41","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:240600","disease_name":"Glycogen storage disease 0, liver","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0011998","is_excluded":false,"label":"Postprandial hyperglycemia","onset_id":null,"reference":"OMIM:240600","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"359df3821f82b6d5edf3db58e59ad079f5e7c0221c38cb36f908bbb826383660","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:2089","disease_name":"Glycogen storage disease due to hepatic glycogen synthase deficiency","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001250","is_excluded":false,"label":"Seizure","onset_id":null,"reference":"ORPHA:2089","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"36d21d2be2b90fbb26b0ff58788219f359580e0cf3ace133c4d3428c4045665e","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:2089","disease_name":"Glycogen storage disease due to hepatic glycogen synthase deficiency","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0011998","is_excluded":false,"label":"Postprandial hyperglycemia","onset_id":null,"reference":"ORPHA:2089","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"4fa4b997d963a5e763ca9634e447dbbf4df068ac96e35a59163b6defc1421c02","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:2089","disease_name":"Glycogen storage disease due to hepatic glycogen synthase deficiency","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0002919","is_excluded":false,"label":"Ketonuria","onset_id":null,"reference":"ORPHA:2089","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"5c32dc3124cfecaf4c8907819a868b3c4c512221e1a3d75591646167a3571164","raw":{"aspect":"P","body_system":"growth","disease_id":"ORPHA:2089","disease_name":"Glycogen storage disease due to hepatic glycogen synthase deficiency","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0004322","is_excluded":false,"label":"Short stature","onset_id":null,"reference":"ORPHA:2089","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"66eb2bdae3ce9acc838b66ffd4b736726ae43965bf3e0f9ef9b5b08d04b7e47b","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:240600","disease_name":"Glycogen storage disease 0, liver","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0001998","is_excluded":false,"label":"Neonatal hypoglycemia","onset_id":null,"reference":"OMIM:240600","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"68bb57d55b9757dd1d654930773cd3346ca4ee03d12ded0a32be92bc0f569538","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:240600","disease_name":"Glycogen storage disease 0, liver","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0001250","is_excluded":false,"label":"Seizure","onset_id":null,"reference":"OMIM:240600","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"6c032d0c9c441dde07843c9bb68e47066d0cd300e9186b8ec0be4eeba87ebe1c","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:240600","disease_name":"Glycogen storage disease 0, liver","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0003162","is_excluded":false,"label":"Fasting hypoglycemia","onset_id":null,"reference":"OMIM:240600","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"8d8ed540e725285490262a456e807bcd7baf12286a609d4b86015973f6ee7c22","raw":{"aspect":"P","body_system":"growth","disease_id":"ORPHA:2089","disease_name":"Glycogen storage disease due to hepatic glycogen synthase deficiency","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001508","is_excluded":false,"label":"Failure to thrive","onset_id":null,"reference":"ORPHA:2089","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"8e1ba19ac89a5a2bc1d9e0172ba080b09bd68b49c2e52c584be4336d07a8b5c0","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:2089","disease_name":"Glycogen storage disease due to hepatic glycogen synthase deficiency","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0003077","is_excluded":false,"label":"Hyperlipidemia","onset_id":null,"reference":"ORPHA:2089","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"952a72076a584a23b7cff10ac810e6c99ff913738ed2fc3dcab4fbdb1d156caf","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:240600","disease_name":"Glycogen storage disease 0, liver","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0002151","is_excluded":false,"label":"Increased circulating lactate concentration","onset_id":null,"reference":"OMIM:240600","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"9fafe0256c12ed93e8a396d4f37cc40c6de5d1b86c1969a29463e7c25903520b","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:2089","disease_name":"Glycogen storage disease due to hepatic glycogen synthase deficiency","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0012734","is_excluded":false,"label":"Ketotic hypoglycemia","onset_id":null,"reference":"ORPHA:2089","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"bfd14e327003bb87f0caef6b153cdd3c5c9965f156e98404207ec3d49d37fbbe","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:2089","disease_name":"Glycogen storage disease due to hepatic glycogen synthase deficiency","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0003076","is_excluded":false,"label":"Glycosuria","onset_id":null,"reference":"ORPHA:2089","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"d66a748a831364ac6067d36bbd0723058ee01de7d7627aab896c6b3288df84bb","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:2089","disease_name":"Glycogen storage disease due to hepatic glycogen synthase deficiency","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001263","is_excluded":false,"label":"Global developmental delay","onset_id":null,"reference":"ORPHA:2089","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"f00a86806526af7595201c792de0b8964b60a7c6fb4f6067a187e0c6d3d8e805","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:240600","disease_name":"Glycogen storage disease 0, liver","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0001946","is_excluded":false,"label":"Ketosis","onset_id":null,"reference":"OMIM:240600","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"fc1d0fa8eee100a2f26fd4f727ed02f03c3cdeef4d48440ef322a50d41d8f177","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:2089","disease_name":"Glycogen storage disease due to hepatic glycogen synthase deficiency","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001254","is_excluded":false,"label":"Lethargy","onset_id":null,"reference":"ORPHA:2089","source_release":"2026-06-23"},"sourceGroups":["orphanet"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/2513\" rel=\"noreferrer\">GARD</a></p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0009414\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>summary</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-identity-and-attribution</dd><dt>Upstream attribution</dt><dd>GARD:0002513</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>Glycogen storage disease type 0 (also known as GSD 0) is a condition caused by the body&#x27;s inability to form a complex sugar called glycogen, which is a major source of stored energy in the body. GSD 0 has two types: in muscle GSD 0, glycogen formation in the muscles is impaired, and in liver GSD 0, glycogen formation in the liver is impaired. The signs and symptoms of muscle GSD 0 typically begin in early childhood. Affected individuals often experience muscle pain and weakness or episodes of fainting (syncope) following moderate physical activity, such as walking up stairs. The loss of consciousness that occurs with fainting typically lasts up to several hours. Some individuals with muscle GSD 0 have a disruption of the heart&#x27;s normal rhythm (arrhythmia) known as long QT syndrome. In all affected individuals, muscle GSD 0 impairs the heart&#x27;s ability to effectively pump blood and increases the risk of cardiac arrest and sudden death, particularly after physical activity. Sudden death from cardiac arrest can occur in childhood or adolescence in people with muscle GSD 0. Individuals with liver GSD 0 usually show signs and symptoms of the disorder in infancy. People with this disorder develop low blood sugar (glucose), known as hypoglycemia, after going long periods of time without food (fasting). Signs of hypoglycemia become apparent when affected infants begin sleeping through the night and stop late-night feedings; these infants exhibit extreme tiredness (lethargy), pale skin (pallor), and nausea. During episodes of fasting, ketone levels in the blood may increase (ketosis). Ketones are molecules produced during the breakdown of fats, which occurs when stored sugars (such as glycogen) are unavailable. These short-term signs and symptoms of liver GSD 0 often improve when food is eaten and glucose levels in the body return to normal. The features of liver GSD 0 vary; they can be mild and go unnoticed for years, or they can include developmental delay and growth failure.</p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/2513\" rel=\"noreferrer\">GARD</a></p>","key":"overview","title":"Overview"}],"sharedSources":[],"slug":"glycogen-storage-disorder-due-to-hepatic-glycogen-synthase-deficiency","sourceDocuments":[{"name":"GARD: Glycogen storage disorder due to hepatic glycogen synthase deficiency","reviewed":null,"source_release":"2026-10-21T17:04:04Z","url":"https://rarediseases.info.nih.gov/diseases/2513"},{"name":"MONDO: glycogen storage disorder due to hepatic glycogen synthase deficiency","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0009414"}],"sourceNote":"","synonyms":["glycogen storage disease 0, liver","glycogen storage disease due to glycogen synthase deficiency of liver","glycogen storage disease due to hepatic glycogen synthase deficiency","glycogen storage disease due to liver glycogen synthase deficiency","glycogen storage disease type 0, liver","glycogen storage disease type 0a","glycogen synthase deficiency","glycogenosis type 0a","GSD due to hepatic glycogen synthase deficiency","GSD type 0a","GSD0A","hepatic glycogen synthase deficiency","hypoglycemia with deficiency of glycogen synthetase in the liver","liver glycogen storage disease due to glycogen synthase deficiency","liver GSD 0"],"takeawayHtml":"","title":"glycogen storage disorder due to hepatic glycogen synthase deficiency"},"schemaVersion":1}
